ACE2 protein protects against severe COVID-19
- Details
- Category: Research
"The highlight of our study is how the sex differences in COVID-19 are linked to ACE2," said senior author Gavin Oudit, professor of medicine in the Faculty of Medicine & Dentistry, Canada Research Chair in Heart Failure and director of the Heart Function Clinic at the Mazankowski Alberta Heart Institute.
Remdesivir likely to be highly effective antiviral against SARS-CoV-2
- Details
- Category: Research
Oral drug blocks SARS-CoV-2 transmission
- Details
- Category: Research
The group led by Dr. Richard Plemper, Distinguished University Professor at Georgia State, originally discovered that the drug is potent against influenza viruses.
Study finds metformin reduced COVID-19 death risks in women
- Details
- Category: Research
Metformin is an established, generic medication for managing blood sugar levels in patients with type 2 diabetes.
KU Leuven vaccine candidate protects against COVID-19 and yellow fever
- Details
- Category: Research
Predict cellular drug targets against COVID-19
- Details
- Category: Research
Doctors use existing treatment earlier to save the lives of COVID-19 patients
- Details
- Category: Research
Dr Luigi Sedda of Lancaster University analysed the results from the team at Wrightington, Wigan and Leigh Teaching Hospitals NHS Trust (WWL). Their research has now been published in the prestigious medical journal BMJ Respiratory Open.
More Pharma News ...
- New therapy for flu may help in fight against COVID-19
- The drug aprotinin inhibits entry of SARS-CoV2 in host cells
- Chinese vaccine candidate based on inactivated SARS-CoV-2 virus appears safe and induces an immune response in healthy volunteers
- Phase 2 trial of Oxford COVID-19 vaccine in healthy older adults finds it is safe and provokes immune response
- Immunological memory after cured Sars-CoV-2 infection
- Cytokine storms play a limited role in moderate-to-severe COVID-19
- Fluvoxamine may prevent serious illness in COVID-19 patients